openPR Logo
Press release

Digital Diabetes Management Market Research Report 2025 | Global Key Players Medtronic, F. Hoffmann-La Roche Ltd, Dexcom, Inc., Ascensia Diabetes Care Holdings AG., Abbott., B. Braun Melsungen AG, Glooko, LifeScan, Inc. Among Others

Global Digital Diabetes Management Market

Global Digital Diabetes Management Market

Global Digital Diabetes Management Market is expected to rise from its initial estimated value of USD 5.4 billion to an estimated value of USD 30.56 billion by 2026, registering a CAGR of 23.95% in the forecast period of 2019-2026. Increasing prevalence of diabetics is major factor for the growth of this market.

Get Free Sample Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-digital-diabetes-management-market

Global Digital Diabetes Management Market Key Competitors:

Few of the major competitors currently working in the digital diabetes management market are Medtronic, F. Hoffmann-La Roche Ltd, Dexcom, Inc., Ascensia Diabetes Care Holdings AG., Abbott., B. Braun Melsungen AG, Glooko, LifeScan, Inc., AgaMatrix Inc., Tandem Diabetes Care, Inc., Insulet Corporation, DarioHealth.

Key Developments in the Market:

• In August 2018, Healthy interactions and Merck announced the launch of the new diabetes management and engagement platform designed to support in- person counselling programs, The map4health platform. It includes a patient-facing app that consists of text and video messaging, goal tracking, and peer support forums. The platform is designed for diabetes patients and also be used as standalone tool or integrated into a diabetes self-management education or support (DSMES) program.
• DarioHealth Corp. announced the launch of their version 4.1 of their Dario® App for the Dario Blood Glucose Monitoring System, part of the DarioHealth digital diabetes data management platform. It is fully- integrated with the DarioEngage patient management and coaching platform which will results in sustainable user behavior changes and associated positive clinical outcomes.

Global Digital Diabetes Management Market Table Of Content:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Global Digital Diabetes Management Market Landscape

Part 04: Global Digital Diabetes Management Market Sizing

Part 05: Global Digital Diabetes Management Market Segmentation By Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

And More…Get Detailed TOC | At https://databridgemarketresearch.com/toc/?dbmr=global-digital-diabetes-management-market

Market Drivers:

Technological advancement is driving the market.
Growing adoption of cloud-based enterprise solutions for diabetes management is driving the market.

Market Restraints:

High cost of the device is restraining the market.
Preference of traditional diabetes management devices is restraining the market.
Preference of traditional diabetes management devices is restraining the market.
Global Digital Diabetes Management Market
Segmentation:

• By Type

o Wearable Devices
o Handheld Devices

• By Product and Services

o Devices
 Smart Glucose Meters
 Continuous Glucose Monitoring Systems
 Smart Insulin Pens
 Smart Insulin Pumps/Closed-Loop Systems and Smart Insulin Patches
o Digital Diabetes Management Apps
 Diabetes and Blood Glucose Tracking Apps
 Weight and Diet Management Apps
o Data Management Software and Platforms
o Services

• By End- User

o Self/Home Healthcare
o Hospitals & Specialty Diabetes Clinics
o Academic & Research Institutes

• By Geography

Global Digital Diabetes Management Market Competitive Analysis:

Global digital diabetes management market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of digital diabetes management market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Inquiry Before Buying at https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-digital-diabetes-management-market

Data Bridge Market Research

Office Number 402, Amanora Chambers,
Magarpatta Road, Hadapsar
Pune – 411028
Maharashtra, India
Email: sopan.gedam@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Diabetes Management Market Research Report 2025 | Global Key Players Medtronic, F. Hoffmann-La Roche Ltd, Dexcom, Inc., Ascensia Diabetes Care Holdings AG., Abbott., B. Braun Melsungen AG, Glooko, LifeScan, Inc. Among Others here

News-ID: 1782985 • Views: 1011

More Releases from Data Bridge Market Research

Global Tamiflu (Oseltamivir Phosphate) Drugs Market Worldwide Business Growth An …
Global Tamiflu (oseltamivir phosphate) drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market. This Tamiflu (oseltamivir phosphate) drugs market research report is one of the unsurpassed
Global Peptide Antibiotics Market To See Tremendous Growth | Leading Players Are …
Peptide antibiotics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of the infectious diseases worldwide and recently approval of the drug are the factors responsible for the growth of this market. This Peptide antibiotics market research report is one of the unsurpassed and
Global Tumor Lysis Syndrome Market 2020:Size, Industry Status and Growth opportu …
Global tumor lysis syndrome market is rising gradually with a substantial CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. The growth in this market can be attributed to factors such as development of innovative therapies. Few of the major competitors currently working in the global tumor lysis syndrome market areSanofi, The Menarini Group, Merck KGaA, Takeda Pharmaceutical Company Limited,
Global Proctitis Market 2020:Current Trends and Technology Enhancements with Top …
Proctitis market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of the inflammatory diseases worldwide and emerging markets are the factors responsible for the growth of this market. The statistical and numerical data collected to generate this credible market report is mostly denoted with

All 5 Releases


More Releases for Diabetes

Global Diabetes Industry
Global Diabetes Industry Market Insight Global diabetes market is expected to grow at a CAGR of 7.9% percent for the forecasted period of 2016-2021. The market is segmented on the basis of type of diabetes, drugs class and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 9%. Some of the top selling
27th European Diabetes Congress
Rising awareness, new technologies and practical approaches within the field of diabetes and endocrine disorders in world’s leading diabetes Conferences One in eight ladies can develop a diabetes disorder throughout her lifespan. And, the amount of individuals affected by diabetes disorders continues to rise every year. However the larger drawback is that almost 60 minutes of those individuals are fully unaware of their condition as well as a way to heal
27th European Diabetes Congress
We would like to invite your team as a Speakers/Delegates. On behalf of Organizing Committee, we take this opportunity in extending a warm and cordial welcome to you to be part of “27th European Diabetes Congress”, held conjointly with multifarious scientific associations, eminent researchers and scholars from all around the globe during June 20-21, 2018 at Rome, Italy. It is an immense pleasure and privilege having you here with us
Global Diabetes Management Devices Market
ReportsWorldwide has announced the addition of a new report title Global Diabetes Management Devices Market to its growing collection of premium market research reports. The global market for diabetes management devices is a substantial, highly competitive market driven by highly sophisticated, evolving technology, particularly in the insulin pump/artificial pancreas and CGM area. The report provides the following useful information: • diabetes overview • key statistics on diabetes prevalence in major regions in the world • medical device product
Non Invasive Diabetes Therapy Market
The role of non-invasive therapy for diabetes market has been on a positive growth path in healthcare industry since 2014. Though the non-invasive therapy concept was brought way back in 1980, the market has not gained much attention leading to development of fewer such devices. DexCom's seven system and Medtronic's Guardian real-time glucose monitoring system are two such products developed and marketed worldwide. The influx of non-invasive therapy has reinforced
Diabetes Gastroparesis Market grows with rising prevalence of diabetes
Diabetes type 1 and type 2 are one of the most common chronic diseases prevalent in the world, affecting millions of people. One of the disorders associated with diabetes type 1 and type 2 is gastroparesis, which is characterized by the delayed emptying of the stomach. One of the major causes of gastroparesis is damage to the vagus nerve, reducing the mobility of the stomach contents. Diabetic neuropathy affects the